Nuvectis Pharma, Inc.
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 | FY 12/31/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Operating income | -$27.6 | -$19.8 | -$22.9 | -$19.2 | -$12.9 |
| Net income | -$26.4 | -$19.0 | -$22.3 | -$19.1 | -$12.9 |
Shares outstanding 32.6M · Free float 62.2%
Annual filing data through FY ended December 31, 2025; float as of October 6, 2026.